UGP2, a novel target gene of TP53, inhibits endothelial cells apoptosis and atherosclerosis
- 14 January 2025
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 363, 123393
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2021YFA1300604)
- Southern Medical University (2021B023)
- National Natural Science Foundation of China (82402684, 820708121)
- National Science Fund for Distinguished Young Scholars (82025024, 82230080)
- Guangzhou Municipal Science and Technology Program key projects (2025A04J4120)
This publication has 46 references indexed in Scilit:
- Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseasesActa Neuropathologica, 2019
- Identification of UGP2 as a progression marker that promotes cell growth and motility in human gliomaJournal of Cellular Biochemistry, 2019
- Transcriptome‐Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver CancerHepatology, 2018
- Vascular endothelium – Gatekeeper of vessel healthAtherosclerosis, 2016
- Chemokines and microRNAs in atherosclerosisCellular and Molecular Life Sciences, 2015
- p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53‐Lys118 acetylationEMBO Molecular Medicine, 2013
- p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1Virchows Archiv, 2013
- Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stressesJournal of Human Genetics, 2004
- Apoptosis in atherosclerosis: pathological and pharmacological implicationsPharmacological Research, 2001
- Localization of the HumanUGP2Gene Encoding the Muscle Isoform of UDPglucose Pyrophosphorylase to 2p13–p14 by Fluorescencein SituHybridizationGenomics, 1997